Inhibitive effects of 15-deoxy-Δ12,14-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis

OncoTargets and Therapy

Volumn 8, Issue , 2015, Pages 3585-3593

  Chen, Kan ^a   Dai, Weiqi ^a   Wang, Fan ^a   Xia, Yujing ^a   Li, Jingjing ^a   Li, Sainan ^a   Liu, Tong ^a   Zhang, Rong ^b   Wang, Jianrong ^b   Lu, Wenxia ^b   Zhou, Yuqing ^c   Yin, Qin ^c   Zheng, Yuanyuan ^a   Abudumijiti, Huerxidan ^a   Chen, Rongxia ^a   Lu, Jie ^a   Zhou, Yingqun ^a   Guo, Chuanyong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

15 deoxy 12; 14 prostaglandin J2; Apoptosis; Hepatoma cell; JNK; ROS

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CASPASE 3; CASPASE 8; CASPASE 9; CHOLECYSTOKININ OCTAPEPTIDE; CYTOCHROME C; HYDROETHIDINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOCHEMISTRY; DOWN REGULATION; DRUG CYTOTOXICITY; ENZYME ACTIVATION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; TIME; WESTERN BLOTTING;

EID: 84949636601     PISSN: 11786930     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S92832     Document Type: Article

References (37)

1. Cheng P, Dai W, Wang F, et al. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways. Biochem Biophys Res Commun. 2014; 443(4): 1162-1168.
2. Yang J, Li J, Dai W, et al. Golgi protein 73 as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis. Exp Ther Med. 2015; 9(4): 1413-1420.
3. Dai W, Wang C, Wang F, et al. Anti-miR-197 inhibits migration in HCC cells by targeting KAI 1/CD82. Biochem Biophys Res Commun. 2014; 446(2): 541-548.
4. Jie L, Fan W, Weiqi D, et al. The hippo-yes association protein pathway in liver cancer. Gastroenterol Res Pract. 2013; 2013: 187070.
5. De Giorgi V, Buonaguro L, Worschech A, et al. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS One. 2013; 8(2): e56153.
6. Gerardi AM, Stoppino LP, Liso A, Macarini L, Landriscina M. Rapid long-lasting biochemical and radiological response to sorafenib in a case of advanced hepatocellular carcinoma. Oncol Lett. 2013; 5(3): 975-977.
7. Wang F, Dai W, Wang Y, et al. The synergistic in vitro and in vivo antitumor effect of combination therapy with salinomycin and 5-fluorouracil against hepatocellular carcinoma. PLoS One. 2014; 9(5): e97414.
8. Li CC, Yang HT, Hou YC, Chiu YS, Chiu WC. Dietary fish oil reduces systemic inflammation and ameliorates sepsis-induced liver injury by up-regulating the peroxisome proliferator-activated receptor gamma-mediated pathway in septic mice. J Nutr Biochem. 2014; 25(1): 19-25.
9. Chen K, Li J, Wang J, et al. 15-Deoxy-γ12, 14-prostaglandin J2 reduces liver impairment in a model of ConA-induced acute hepatic inflammation by activation of PPARγ and reduction in NF-κB activity. PPAR Res. 2014; 2014: 215631.
10. Date M, Fukuchi K, Morita S, Takahashi H, Ohura K. 15-Deoxy-Δ12, 14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-γ, induces apoptosis in human hepatoma cells. Liver Int. 2003; 23(6): 460-466.
11. Li MY, Deng H, Zhao JM, Dai D, Tan XY. Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World J Gastroenterol. 2003; 9(8): 1683-1688.
12. Brockman JA, Gupta RA, Dubois RN. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology. 1998; 115(5): 1049-1055.
13. Yen CC, Hsiao CD, Chen WM, et al. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition. Oncotarget. 2014; 5(3): 716-725.
14. Lee SJ, Kim MS, Park JY, Woo JS, Kim YK. 15-Deoxy-Δ12, 14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells. Toxicology. 2008; 248(2-3): 121-129.
15. Kitz K, Windischhofer W, Leis HJ, Huber E, Kollroser M, Malle E. 15-Deoxy-Δ12, 14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species. Free Radic Biol Med. 2011; 50(7): 854-865.
16. Kondo M, Oya-Ito T, Kumagai T, Osawa T, Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J Biol Chem. 2001; 276(15): 12076-12083.
17. Fukushima M. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukot Essent Fatty Acids. 1992; 47(1): 1-12.
18. Shibata T, Yamada T, Ishii T, et al. Thioredoxin as a molecular target of cyclopentenone prostaglandins. J Biol Chem. 2003; 278(28): 26046-26054.
19. Ishii T, Uchida K. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-Δ12, 14-prostaglandin J2. Chem Res Toxicol. 2004; 17(10): 1313-1322.
20. Ishii T, Sakurai T, Usami H, Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome. Biochemistry. 2005; 44(42): 13893-13901.
21. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007; 8(10): 813-824.
22. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000; 408(6809): 239-247.
23. Davis W Jr, Ronai Z, Tew KD. Cellular thiols and reactive oxygen species in drug-induced apoptosis. Biochem Pharmacol. 1995; 50(7): 1021-1029.
24. Li D, Ueta E, Kimura T, Yamamoto T, Osaki T. Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci. 2004; 95(8): 644-650.
25. Shin SW, Seo CY, Han H, et al. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res. 2009; 15(17): 5414-5425.
26. Maga G, Hübscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci. 2003; 116(Pt 15): 3051-3060.
27. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991; 51(3): 794-798.
28. Kuntz S, Mazerbourg S, Boisbrun M, et al. Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones. Biochem Pharmacol. 2014; 92(1): 102-111.
29. Petros JA, Baumann AK, Ruiz-Pesini E, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A. 2005; 102(3): 719-724.
30. Gao N, Ding M, Zheng JZ, et al. Vanadate-induced expression of hypoxia-inducible factor 1α and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J Biol Chem. 2002; 277(35): 31963-31971.
31. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 2000; 407(6802): 390-395.
32. Pelicano H, Feng L, Zhou Y, et al. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J Biol Chem. 2003; 278(39): 37832-37839.
33. Brazil DP, Hemmings BA. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci. 2001; 26(11): 657-664.
34. Uchida K, Shibata T. 15-Deoxy-Δ12, 14-prostaglandin J2: an electrophilic trigger of cellular responses. Chem Res Toxicol. 2008; 21(1): 138-144.
35. Park SW, Cho C, Cho BN, Kim Y, Goo TW, Kim YI. 15-Deoxy-Δ12, 14-prostaglandin J2 down-regulates activin-induced activin receptor, Smad, and cytokines expression via suppression of NF-κB and MAPK signaling in HepG2 cells. PPAR Res. 2013; 2013: 751261.
36. Han H, Shin SW, Seo CY, et al. 15-Deoxy-Δ12, 14-prostaglandin J2 (15d-PGJ2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. Apoptosis. 2007; 12(11): 2101-2114.
37. Diers AR, Dranka BP, Ricart KC, et al. Modulation of mammary cancer cell migration by 15-deoxy-Δ(12, 14)-prostaglandin J2: implications for anti-metastatic therapy. Biochem J. 2010; 430(1): 69-78.